- Home
- SWAG vs EVAX Comparison
SWAG vs EVAX Comparison
Compare SWAG & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWAG
- EVAX
- Stock Information
- Founded
- SWAG 1994
- EVAX 2008
- Country
- SWAG United States
- EVAX Denmark
- Employees
- SWAG N/A
- EVAX N/A
- Industry
- SWAG Advertising
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SWAG Consumer Discretionary
- EVAX Health Care
- Exchange
- SWAG Nasdaq
- EVAX Nasdaq
- Market Cap
- SWAG 19.2M
- EVAX 14.5M
- IPO Year
- SWAG 2021
- EVAX 2021
- Fundamental
- Price
- SWAG $1.12
- EVAX $2.71
- Analyst Decision
- SWAG
- EVAX Strong Buy
- Analyst Count
- SWAG 0
- EVAX 2
- Target Price
- SWAG N/A
- EVAX $11.00
- AVG Volume (30 Days)
- SWAG 22.7K
- EVAX 71.1K
- Earning Date
- SWAG 11-04-2024
- EVAX 08-14-2024
- Dividend Yield
- SWAG N/A
- EVAX N/A
- EPS Growth
- SWAG N/A
- EVAX N/A
- EPS
- SWAG 0.00
- EVAX N/A
- Revenue
- SWAG $75,893,871.00
- EVAX $278,000.00
- Revenue This Year
- SWAG $11.55
- EVAX $495.23
- Revenue Next Year
- SWAG N/A
- EVAX $0.94
- P/E Ratio
- SWAG $594.45
- EVAX N/A
- Revenue Growth
- SWAG 28.74
- EVAX N/A
- 52 Week Low
- SWAG $0.91
- EVAX $2.26
- 52 Week High
- SWAG $1.74
- EVAX $13.61
- Technical
- Relative Strength Index (RSI)
- SWAG 44.64
- EVAX 43.26
- Support Level
- SWAG $1.08
- EVAX $2.58
- Resistance Level
- SWAG $1.16
- EVAX $2.78
- Average True Range (ATR)
- SWAG 0.06
- EVAX 0.21
- MACD
- SWAG -0.00
- EVAX -0.02
- Stochastic Oscillator
- SWAG 20.10
- EVAX 40.28
About SWAG Stran & Company Inc.
Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, It offer its clients with custom sourcing capabilities which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, and event assets, order and inventory management, and designing and hosting online retail popup shops. The company purchases products and branding through various third-party manufacturers and decorators and resells the finished goods to customers.
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.